Pharming Group N.V. PHAR
Set alert
12.23 USD -0.01 -0.10%
At close · Oct 30
12.23 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
12.09 Day range 12.31
9.11 52-week range 21.18
- YTD
- -30.79%
- 1 year
- -6.93%
- Open
- 12.18
- Prev close
- 12.24
- Mkt cap
- 865.62M
- Vol
- 14.05K
- Avg vol
- 24.59K
- EPS
- 0.32
- P/E
- 38.22
- Div yield
- 0.00%
More statistics
- Low
- 12.09
- High
- 12.31
- Forward P/E
- 216.49
- Beta
- 0.09
- Short ratio
- 0.38
- Inst. own
- 0.14%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 13.57
- 200-d avg
- 15.63
- 1y target
- 34.35
Financial health
Altman Z-Score
3.08 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B+3 / 5 overall
- DCF 4
- Return on Equity 3
- Return on Assets 4
- Debt / Equity 2
- P/E 2
- P/B 3
Valuation
P/E 442×
FY 2016 5y median 39.4× FY 2025
P/S 3.4×
FY 2016 5y median 3.4× FY 2025
P/B 4.5×
FY 2016 5y median 3.6× FY 2025
P/FCF 23.4×
FY 2016 5y median 23.4× FY 2025
EV/EBITDA 35.4×
FY 2016 5y median 35.4× FY 2025
EV/Sales 3.3×
FY 2016 5y median 3.5× FY 2025
FCF Yield 4.3%
FY 2016 5y median 2.2% FY 2025
Profitability
Gross Margin 87.9%
FY 2016 5y median 89.4% FY 2025
Operating Margin 5.6%
FY 2016 5y median 4.8% FY 2025
Net Margin 0.8%
FY 2016 5y median 0.8% FY 2025
ROE 1.0%
FY 2016 5y median 1.0% FY 2025
ROIC 1.0%
FY 2016 5y median 1.0% FY 2025
ROA 0.6%
FY 2016 5y median 0.6% FY 2025
Growth (YoY)
Revenue 26.6%
FY 2016 FY 2025
Operating Income 669.7%
FY 2016 FY 2025
EPS (diluted) 122.2%
FY 2016 FY 2025
Free Cash Flow 2182.3%
FY 2016 FY 2025
Financial Health
Current Ratio 2.6×
FY 2016 5y median 4.1× FY 2025
Quick Ratio 2.0×
FY 2016 5y median 3.3× FY 2025
Debt / Equity 0.4×
FY 2016 5y median 0.8× FY 2025
Net Debt / EBITDA -0.9×
FY 2016 5y median -0.7× FY 2025
Interest Coverage 1.9×
FY 2016 5y median 1.8× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31